Ivabradine Shortage Update: What Patients Need to Know in 2026

If you take Ivabradine (Corlanor) for heart failure and you've had trouble finding it at your pharmacy, you're understandably worried. This guide gives you the current status of Ivabradine availability in 2026, explains why some patients are having trouble, and tells you exactly what to do.

Is Ivabradine in an Official FDA Shortage in 2026?

As of 2026, Ivabradine is NOT on the FDA's official Drug Shortage Database. This is important: it means there is no declared, nationwide supply disruption at the manufacturing level. Ivabradine's manufacturer (Amgen, for brand-name Corlanor) has not notified the FDA of a shortage.

However, "not in official shortage" doesn't always mean "easy to find." Many patients still experience gaps at their local pharmacy. Here's why.

Why Some Patients Are Having Trouble Finding Ivabradine

Limited stocking by community pharmacies: Ivabradine is a specialty cardiac medication with a narrow patient population. Most community pharmacies stock medications based on local demand, and they may keep very small quantities on hand or order it only when needed.

Brand-name price barrier: Brand-name Corlanor retails for $800+ per month without insurance, which limits uptake and can affect which pharmacies choose to stock it.

Generic availability varies: The FDA-approved generic Ivabradine tablets are available, but not uniformly distributed across all pharmacy chains. Some pharmacies may carry the brand but not the generic, or vice versa.

Prior authorization delays: Insurance prior authorization is frequently required and can take days to weeks. This can create a perceived "unavailability" that is really an insurance access problem, not a drug supply problem.

Historical Context: Has Ivabradine Been in Shortage Before?

Ivabradine has not had a major, declared national shortage since the FDA approved it in 2015. This is in contrast to drugs like semaglutide (Ozempic/Wegovy), amphetamine salts (Adderall), and various chemotherapy drugs that appeared on the FDA shortage list in recent years.

The "shortage" patients experience with Ivabradine is primarily a distribution and access issue — a combination of limited pharmacy stocking, insurance hurdles, and price — rather than a manufacturing crisis.

What the Generic Ivabradine Situation Means for Patients

The availability of FDA-approved generic Ivabradine tablets is genuinely good news for patients. Generic drugs are bioequivalent to the brand-name version and typically cost dramatically less. While brand-name Corlanor can run over $800 per month at retail, generic Ivabradine can be obtained for as little as $55-$150 per month with a GoodRx or SingleCare coupon.

If you've had trouble with Corlanor availability or cost, ask your prescriber to write your prescription for 'Ivabradine' (generic) and confirm with your pharmacist that they stock the generic version.

What Patients Should Do Right Now

Don't stop taking Ivabradine abruptly. If you're running low, contact your doctor immediately.

Ask about generic Ivabradine. Ask your pharmacist and prescriber whether generic Ivabradine HCl tablets are available and appropriate for you.

Use medfinder to locate a pharmacy. medfinder calls pharmacies near you to find out which ones can fill your Ivabradine prescription and texts you the results.

Check insurance and prior authorization. If your prescription is stuck in the PA process, ask your prescriber's office to escalate. Many PA submissions can be expedited if marked urgent.

Explore patient assistance. The Amgen Safety Net Foundation provides free Corlanor to qualifying patients (uninsured or underinsured, income at or below 300% of the federal poverty level). Call 1-888-762-6436.

Consider mail order. Mail-order pharmacies that specialize in cardiac medications tend to stock Ivabradine more reliably than small community pharmacies.

The Bottom Line

There is no FDA-declared national shortage of Ivabradine in 2026. The access challenges patients face are primarily related to pharmacy stocking practices, insurance barriers, and the cost of the brand-name drug. Generic Ivabradine is available and significantly more affordable. If you've been unable to fill your prescription, explore generic options, use medfinder to locate a stocking pharmacy, and contact your prescriber. If long-term access remains a concern, learn about alternatives to Ivabradine that your cardiologist may consider.